<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="discussion" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1640740</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2025.1640740</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Opinion</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Integrating thermodynamics and molecular kinetics into western blotting teaching</article-title>
<alt-title alt-title-type="left-running-head">Wang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2025.1640740">10.3389/fmolb.2025.1640740</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Zhiyong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Min</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Yanxin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1100411/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xia</surname>
<given-names>Qiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wei</surname>
<given-names>Pei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2547714/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Immunology, Zhuhai Campus of Zunyi Medical University</institution>, <addr-line>Zhuhai</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pharmaceutics, Zhuhai Campus of Zunyi Medical University</institution>, <addr-line>Zhuhai</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/598648/overview">Barbara Cellini</ext-link>, University of Perugia, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/603567/overview">Margarita Isabel Palacios-Arreola</ext-link>, National Autonomous University of Mexico, Mexico</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Zhiyong Wang, <email>wangzhiyong@zmuzh.edu.cn</email>; Pei Wei, <email>weipei@zmuzh.edu.cn</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1640740</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>07</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Wang, Wang, Yu, Lu, Xia and Wei.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wang, Wang, Yu, Lu, Xia and Wei</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<kwd-group>
<kwd>Western blotting</kwd>
<kwd>antigen (Ag)</kwd>
<kwd>antibody (Ab)</kwd>
<kwd>thermodynamics</kwd>
<kwd>kinetics</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Protein Biochemistry for Basic and Applied Sciences</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The Western blotting technique, which was first detailed by <xref ref-type="bibr" rid="B46">Towbin et al. (1979)</xref>, is mainly used for the identification of proteins from complex biological samples. It sensitively detects and quantifies specific proteins from fairly complex biological mixtures, offering a great potential for new discoveries in the field of life sciences (<xref ref-type="bibr" rid="B43">Sule et al., 2023</xref>; <xref ref-type="bibr" rid="B23">Meftahi et al., 2021</xref>; <xref ref-type="bibr" rid="B2">Begum et al., 2022</xref>). Even in basic laboratories, immunodetection is a challenging phase, which can result in extremely weak or no signals. In addition, enhanced background, non-specific bands, or uneven banding of the samples can be commonly observed, leading to false positive or negative results (<xref ref-type="bibr" rid="B19">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="B3">Butler et al., 2019</xref>). In traditional modes of teaching, these problems are assumed to be solved through the empirical adjustment of the experimental conditions. These adjustments include modification of antibody concentration, incubation time, or blocking reagents without strongly linking various causes to unifying the conceptual framework for students. Much reliance on experimental trial-and-error instead of systematic hypothesis testing leads to such problems.</p>
<p>Herein, we introduced thermodynamic concepts and principles of molecular thermal motion to provide a robust and unified framework for Western blotting. The thermodynamics of antigen-antibody interaction are governed by Gibbs free energy (&#x394;<italic>G</italic>), which is a combined contribution of enthalpy change (&#x394;<italic>H</italic>) and entropy change (&#x394;<italic>S</italic>) (<xref ref-type="bibr" rid="B37">Sagawa et al., 2003</xref>; <xref ref-type="bibr" rid="B44">Tamil et al., 2002</xref>). Kinetically, these interactions are controlled by the association rate constant (k<sub>on</sub>) and the dissociation rate constant (k<sub>off</sub>) (<xref ref-type="bibr" rid="B22">Mason and Williams, 1980</xref>; <xref ref-type="bibr" rid="B34">Rossini and Dimitrov, 2021</xref>). By mapping experimental variables, such as buffer systems, temperature, antibody concentration, and incubation time onto these biophysical parameters (<xref ref-type="bibr" rid="B34">Rossini and Dimitrov, 2021</xref>; <xref ref-type="bibr" rid="B48">Voets, 2017</xref>), students can predict the effect of each adjustment on equilibrium occupancy and kinetic rates and attribute common troubleshooting issues to suboptimal thermodynamic or kinetic conditions. This article first introduces the theoretical basis of antigen-antibody binding and then elucidates how suboptimal conditions can lead to common problems when running Western blotting. Finally, the article proposes teaching design strategies based on this framework.</p>
<p>In accordance with contemporary evidence-based STEM teaching practices, students must apply fundamental principles of the subject to actual predictions of outcome and diagnosis of failure. Students transition from being passive recipients of a protocol to active participants in the intellectual process. This active learning principle supports &#x201c;scientific reasoning&#x201d; by having students formulate hypotheses and devise logical troubleshooting strategies that are grounded in theory. By doing so, students move beyond procedural &#x201c;hands-on learning&#x201d; to a deeper &#x201c;minds-on&#x201d; realization of the actual scientific method.</p>
</sec>
<sec id="s2">
<title>A biophysical primer: key concepts for immunodetection</title>
<p>A solid foundation in biophysical principles governing molecular interactions is needed to evaluate how experimental variables affect Western blotting. The binding between an antibody and its target antigen is a dynamic equilibrium rather than a static event. It is described by laws of thermodynamics and molecular kinetics. We introduce these basic principles in an intuitive way.</p>
<p>Kinetic rate constants are at the center of the interactions (<xref ref-type="fig" rid="F1">Figure 1</xref>). Imagine antibody and antigen molecules to be constantly moving dancers in a crowded ballroom. The association rate constant (k<sub>on</sub>) is the rate at which molecules find each other and pair. This association depends on concentration (more dancers equate to more pairs) and how quickly they can diffuse. The rate at which an existing pair separates is the dissociation rate constant (k<sub>off</sub>)&#x2014;an intrinsic property of how compatible a pair is. As such, a strong couple will separate slowly (low k<sub>off</sub>) but a weak couple will separate quickly (high k<sub>off</sub>). The overall strength (or &#x201c;stickiness&#x201d;) of this interaction is represented as the dissociation constant (K<sub>D</sub>), or the ratio of the two rates: K<sub>D</sub> &#x3d; k<sub>off</sub>/k<sub>on</sub>. A small K<sub>D</sub> value means strong affinity and a stable, long-lived complex (for example, k<sub>off</sub> is very slow or k<sub>on</sub> is very fast, or both). On the contrary, a big K<sub>D</sub> signifies weak affinity and therefore transient interaction. Usually, one uses an antibody with a very low K<sub>D</sub> for the target antigen but a very high K<sub>D</sub> for other membrane proteins.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The dynamic equilibrium of antigen-antibody binding. The interaction between an antibody and its antigen is a reversible process governed by kinetic and thermodynamic principles. The association rate constant (k<sub>on</sub>) describes the speed at which the antibody binds to the antigen to form a complex. The dissociation rate constant (k<sub>off</sub>) describes the speed at which the complex breaks apart. The ratio of these two rates defines the dissociation constant (K<sub>D</sub>), a measure of binding affinity. A low K<sub>D</sub> signifies high affinity. The spontaneity of this binding is determined by the Gibbs free energy change (&#x394;<italic>G</italic>), which is directly related to K<sub>D</sub>.</p>
</caption>
<graphic xlink:href="fmolb-12-1640740-g001.tif">
<alt-text content-type="machine-generated">Antigen-antibody binding equilibrium diagram. Ag (antigen) and Ab (antibody) form an Ag-Ab complex. Forward reaction rate is Kon, reverse is Koff. Equilibrium constant \( K_D &#x3d; \frac{K_{off}}{K_{on}} \). Gibbs free energy equation: \( \Delta G &#x3d; RT \ln (K_D) \).</alt-text>
</graphic>
</fig>
<p>Gibbs free energy change (&#x394;<italic>G</italic>) drives this spontaneous binding. &#x394;<italic>G</italic>, the net change of a reaction in terms of energy, determines whether a reaction proceeds. Affinity relates directly to free energy&#x2014;&#x394;<italic>G</italic> &#x3d; RTln (K<sub>D</sub>)&#x2014;where R is the gas constant and T is absolute temperature. A small K<sub>D</sub> (high affinity) relates to very negative &#x394;<italic>G</italic> (keeping in mind that binding will occur thermodynamically favorably and spontaneously). Positive or about zero &#x394;<italic>G</italic>s suggest the binding is unfavorable and will not occur significantly.</p>
<p>Gibbs free energy is a measure of change in two components&#x2014;enthalpy (&#x394;<italic>H</italic>) and entropy (&#x394;<italic>S</italic>)&#x2014;that are linked by the equation &#x394;<italic>G</italic> &#x3d; &#x394;<italic>H</italic> &#x2212; T&#x394;<italic>S</italic>. &#x394;<italic>H</italic> represents the heat of binding and is caused by energy released from forming favorable noncovalent bonds such as hydrogen bonds, electrostatic interactions, and/or van der-Waals forces. A negative &#x394;<italic>H</italic> contributes favorably to binding. The measure of disorder is entropy (&#x394;<italic>S</italic>). The binding of two molecules into one complex reduces their freedom and is hence entropically unfavorable; an entropic gain would often be more from the release of ordered water molecules at the binding interface. The intricate play between enthalpy and entropy determines &#x394;<italic>G</italic>. This distinction, which contrasts high-affinity specific binding (very negative &#x394;<italic>G</italic>, deep energy well) and low-affinity nonspecific interactions (&#x394;<italic>G</italic> near zero, shallow energy troughs), forms the crux of mastering Western blotting. The difference in conceptual orientation is captured in our energy landscape diagram (<xref ref-type="fig" rid="F2">Figure 2</xref>), which serves throughout the article to clarify how experimental conditions can be manipulated to achieve the selective promotion of the former while minimizing such.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Conceptual energy landscape of molecular interactions in Western blotting. This diagram illustrates the thermodynamic difference between specific and non-specific binding. Specific binding is characterized by a deep energy well (highly negative &#x394;<italic>G</italic>), indicating a stable, high-affinity interaction. In contrast, non-specific interactions are represented by shallow energy troughs (&#x394;<italic>G</italic> near zero), which are unstable and easily disrupted by washing.</p>
</caption>
<graphic xlink:href="fmolb-12-1640740-g002.tif">
<alt-text content-type="machine-generated">Graph showing free energy changes in antigen-antibody interactions. The y-axis represents free energy (\(&#x394;G\)), and the x-axis shows binding states. Initial binding leads to decreased free energy, depicted by a downward arrow. Equation \(&#x394;G &#x3d; &#x394;H - T&#x394;S\) is included. Specific binding shows a deeper energy well compared to non-specific binding.</alt-text>
</graphic>
</fig>
<sec id="s2-1">
<title>Challenges in teaching western blotting</title>
<p>Immunodetection in Western blotting involves incubation with antibodies, washing steps, and signal detection and consists of a series of extremely sensitive biomolecular interactions. The successful results of an experiment rely on the regulation of these events, which can increase the specificity of the obtained signals and decrease background noise (<xref ref-type="bibr" rid="B46">Towbin et al., 1979</xref>). However, in a teaching setting, it usually leads to conceptual misunderstanding among students, leading to their frustration (<xref ref-type="bibr" rid="B47">Tu and Levin, 2022</xref>). They usually experience such challenges because they cannot identify a logical explanation for common conditions, such as no signal or weak signal, enhanced background, or non-specific bands (<xref ref-type="bibr" rid="B46">Towbin et al., 1979</xref>; <xref ref-type="bibr" rid="B16">Kroon et al., 2022</xref>). Problems in antibody affinity, concentration, incubation kinetics, or procedural errors are assumed to be the main culprit (<xref ref-type="bibr" rid="B8">Gilda et al., 2015</xref>).</p>
<p>Teaching methodologies suffer from time or resource limitations. They concentrate too heavily on the &#x201c;how-to&#x201d; of Western blotting and pay less attention to &#x201c;why-it-works.&#x201d; Laboratory procedures should be explained in detail. A superficial learning can be achieved when students heavily rely on doing steps without thinking about the principles. Students never develop the analytical skills needed to address new or complex problems when troubleshooting is presented only in the form of a list of recognized problems and their solutions (<xref ref-type="bibr" rid="B47">Tu and Levin, 2022</xref>). Real experimental skills require analyzing a problem, hypothesizing on the basis of science, and logically designing steps for troubleshooting.</p>
</sec>
<sec id="s2-2">
<title>A unified conceptual framework: thermodynamics and molecular thermal motion in western blotting</title>
<p>Based on the concepts of thermodynamics and theories of molecular thermal motion, we propose an instructional framework to move away from procedural learning and empower students to achieve stronger troubleshooting skills. Although these principles support all chemical and biochemical reactions, they are rarely used in most practical demonstrations of techniques, such as Western blotting.</p>
</sec>
<sec id="s2-3">
<title>Understanding antigen-antibody binding based on thermodynamics and molecular thermal motion</title>
<p>Antigen-antibody binding is an extremely transient and dynamic process characterized by the formation and breakage of molecules via chance encounters (<xref ref-type="bibr" rid="B6">Garc&#xed;a-S&#xe1;nchez et al., 2023</xref>). The chances of such encounters are determined by the Brownian motion of antibody molecules, which are constantly agitated in their liquid environment. The rate of diffusion and collision of antibodies is directly linked to temperature increase. Antigen-antibody binding may be a reversible non-covalent interaction. Their binding strength, or affinity, is expressed as the dissociation constant (K<sub>D</sub>, wherein lower values imply stronger affinity) and as its reciprocal, the association constant (K<sub>A</sub>, wherein higher values imply stronger affinity) (<xref ref-type="bibr" rid="B22">Mason and Williams, 1980</xref>). Both equilibrium constants are linked to the ratio between two rate constants, one for association (k<sub>on</sub>), which describes the bonding speed, and one for dissociation (k<sub>off</sub>), which describes the unbinding speed (K<sub>D</sub> &#x3d; k<sub>off</sub>/k<sub>on</sub>) (<xref ref-type="bibr" rid="B22">Mason and Williams, 1980</xref>; <xref ref-type="bibr" rid="B34">Rossini and Dimitrov, 2021</xref>). The concentration of antigen-antibody binding affinity is correlated with the Gibbs&#x2019; free energy change (&#x394;<italic>G</italic>) of the binding reaction (<xref ref-type="bibr" rid="B37">Sagawa et al., 2003</xref>). The change in Gibbs free energy is defined as &#x394;<italic>G</italic> &#x3d; &#x394;<italic>H</italic>&#x2212;T&#x394;<italic>S</italic>. It indicates the spontaneity of an antigen-antibody (Ag-Ab) binding reaction and its position at equilibrium, with more negative values suggesting stronger binding and stable complexes. This binding strength is also affected by the following variables: enthalpy changes (&#x394;<italic>H</italic>), which represents the net energy change occurring during the formation of non-covalent bonds, including hydrophobic interactions, hydrogen bonds, electrostatic forces, and van der Waals forces; and changes in entropy (&#x394;<italic>S</italic>), which is explicitly associated with solvent reorganization and changes in molecular conformational freedom. Translation or rotational entropy is inhibited in the case of Ag-Ab complexes, while the release of water molecules from the interface during hydrophobic interactions can increase solvent entropy, which often increases the net positive &#x394;<italic>S</italic> (<xref ref-type="bibr" rid="B37">Sagawa et al., 2003</xref>; <xref ref-type="bibr" rid="B40">Schwarz et al., 1995</xref>).</p>
</sec>
<sec id="s2-4">
<title>Interpreting common experimental variables of western blotting through the new framework</title>
<p>By mastering these core principles, students can understand immunodetection steps as a series of molecular interactions governed thermodynamically and kinetically (<xref ref-type="table" rid="T1">Table 1</xref>). Theoretically, this should maximize signal-to-noise ratios. In other words, high-affinity specific Ag-Ab binding (highly negative &#x394;<italic>G</italic>) should be thermodynamically favorable, but interactions of antibodies with other proteins or the membrane itself are thermodynamically unfavorable and result in positive or negligibly negative &#x394;<italic>G</italic>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Biophysical interpretation for Western blotting variables.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Variable</th>
<th align="center">Biophysical rationale</th>
<th align="center">Optimal outcome</th>
<th align="center">Common problems and their biophysical causes</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Temperature</td>
<td align="left">Affects kinetics (k<sub>on</sub>/k<sub>off</sub>), <italic>T&#x394;S</italic> in <italic>&#x394;G</italic>
</td>
<td align="left">Accelerates k<sub>on</sub> to equilibrium without denaturation or high k<sub>off</sub>
</td>
<td align="left">Too high: Protein denaturation (unfavorable <italic>&#x394;G</italic>); high koff causes signal loss<break/>Too low: Slow kinetics (low k<sub>on</sub>); equilibrium not reached</td>
</tr>
<tr>
<td align="center">Antibody Conc</td>
<td align="left">Mass action: higher concentration drives binding</td>
<td align="left">Balances specific signal vs. non-specific binding</td>
<td align="left">Too high: High background from non-specific binding; antibody aggregation<break/>Too low: Weak/no signal from insufficient binding</td>
</tr>
<tr>
<td align="center">Agitation</td>
<td align="left">Enhances mass transport, increasing apparent k<sub>on</sub>
</td>
<td align="left">Uniform, faster binding for a consistent signal</td>
<td align="left">Insufficient: Slow diffusion (low apparent k<sub>on</sub>) causes weak or uneven signals<break/>Too vigorous: Shear forces increase k<sub>off</sub> of weak interactions, causing signal loss</td>
</tr>
<tr>
<td align="center">Blocking</td>
<td align="left">Makes non-specific binding <italic>&#x394;G</italic> unfavorable by occupying sites</td>
<td align="left">Inert surface maximizes signal-to-noise by preventing background</td>
<td align="left">Incomplete: Exposed sites cause non-specific binding (high background)<break/>Excessive: Masks antigen, reducing k<sub>on</sub> (weak signal)</td>
</tr>
<tr>
<td align="center">Washing</td>
<td align="left">Removes non-specifics by leveraging their high k<sub>off</sub>
</td>
<td align="left">Removes non-specific antibodies, reducing background</td>
<td align="left">Too gentle: Fails to remove non-specifics (high background)<break/>Too harsh: Dissociates specific complexes (weak signal)</td>
</tr>
<tr>
<td align="center">pH</td>
<td align="left">Alters protein charge and conformation, affecting <italic>&#x394;H</italic> and <italic>&#x394;S</italic>
</td>
<td align="left">Optimal conformation and charge for most favorable <italic>&#x394;G</italic> (high affinity)</td>
<td align="left">Deviation (too high or low): Reduces affinity (less negative <italic>&#x394;G</italic>); can cause denaturation or non-specific adsorption (high background)</td>
</tr>
<tr>
<td align="center">Ionic Strength</td>
<td align="left">Screens charges and modulates hydrophobic interactions, impacting <italic>&#x394;H</italic> and <italic>&#x394;S</italic>
</td>
<td align="left">Suppresses non-specific electrostatic binding while preserving specific binding</td>
<td align="left">Too high: Weakens specific electrostatic binding (signal loss); increases non-specific hydrophobic binding<break/>Too low: Fails to screen charges; protein aggregation</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-5">
<title>Temperature</title>
<p>Undoubtedly, temperature affects the speed and equilibrium of antigen-antibody binding (<xref ref-type="bibr" rid="B12">Johnstone et al., 1990</xref>). In terms of molecular thermal motion, increasing the temperature enhances the Brownian motion of antibody molecules, thereby increasing their collision frequency with the antigen and elevating the constant for the association rate (k<sub>on</sub>) (<xref ref-type="bibr" rid="B12">Johnstone et al., 1990</xref>; <xref ref-type="bibr" rid="B18">Levison et al., 1968</xref>). Compared to room temperature or 4 &#xb0;C, higher temperatures (for example, 37 &#xb0;C) increase the rate of formation and attainment of the equilibrium in this antigen-antibody complex (<xref ref-type="bibr" rid="B12">Johnstone et al., 1990</xref>; <xref ref-type="bibr" rid="B42">Stan et al., 2019</xref>). However, too high temperatures may lead to adverse results. First, a high temperature may denature antibodies or antigens, disrupt the binding site conformation, and lead to a greater reduction in affinity. Second, since antigen-antibody binding is a reversible reaction, higher temperatures will increase the dissociation rate constant (<xref ref-type="bibr" rid="B12">Johnstone et al., 1990</xref>; <xref ref-type="bibr" rid="B49">Wakayama and Sugiyama, 2012</xref>). Based on Gibbs free energy change &#x394;<italic>G</italic> &#x3d; &#x394;<italic>H</italic>&#x2212;T&#x394;<italic>S</italic> (<xref ref-type="bibr" rid="B48">Voets, 2017</xref>), when the enthalpy change (&#x394;<italic>H</italic>) of binding reaction remains less sensitive to temperature, &#x394;<italic>G</italic> should increase or be positive using sufficiently high temperatures, preventing complex formation and inducing the dissociation of formed complexes. Hence, the temperature for Western blotting should provide a balance between kinetic acceleration and thermodynamic stability (as well as biomolecular activity) (<xref ref-type="bibr" rid="B12">Johnstone et al., 1990</xref>; <xref ref-type="bibr" rid="B42">Stan et al., 2019</xref>).</p>
</sec>
<sec id="s2-6">
<title>Antibody concentration</title>
<p>Antibody concentration determines how fast and how much antigen-antibody binding occurs. According to the law of mass action, the increase in antibody concentration can enhance the probability of collision of antibody molecules with antigens, thereby increasing the association rate constant kon, accelerating complex formation, and favoring the equilibrium toward complex formation (<xref ref-type="bibr" rid="B14">Koch et al., 2018</xref>). This definitely leads to poor detection of low-abundance antigens after a short length of incubation. Extremely high antibody concentrations may allow for more than simple binding to the target antigen and lead to a high collision rate with many non-specific sites on the membrane. In samples with weak binding capabilities (these sites have larger K<sub>D</sub> values, corresponding to less negative &#x394;<italic>G</italic>), this non-specific binding will result in drastically greater cumulative collision numbers at significantly larger K<sub>D</sub> values. These non-specific reactions can increase the background signal, which can overshadow the specific signal (<xref ref-type="bibr" rid="B1">Algen&#xe4;s et al., 2014</xref>; <xref ref-type="bibr" rid="B21">Loeffler and Klaver, 2017</xref>). Collectively, high concentrations of antibodies may promote the aggregation of antibodies, and aggregated antibodies prefer non-specific adsorption (<xref ref-type="bibr" rid="B28">Perchiacca and Tessier, 2012</xref>).</p>
</sec>
<sec id="s2-7">
<title>Agitation</title>
<p>There appears a relatively stagnant liquid layer on the membrane surface during static incubation requiring antibodies to traverse this layer via slow Brownian movement (diffusion) to reach immobilized antigens (<xref ref-type="bibr" rid="B27">Nygren and Stenberg, 1985</xref>; <xref ref-type="bibr" rid="B29">Pereiro et al., 2020</xref>). Broad agitation generates macroscopic convection that effectively thins this stagnant layer, thereby accelerating the migration of antibodies toward the membrane surface and ensuring a more uniform distribution of antibodies throughout the incubation system (<xref ref-type="bibr" rid="B29">Pereiro et al., 2020</xref>; <xref ref-type="bibr" rid="B33">Rathaur et al., 2020</xref>). This increases the chance of effective collision frequency between antibodies and antigens, thereby increasing the apparent association rate constant (k<sub>on</sub>) and contributing to a more rapid and uniform binding (<xref ref-type="bibr" rid="B29">Pereiro et al., 2020</xref>; <xref ref-type="bibr" rid="B10">Hu et al., 2007</xref>). Overzealous or inappropriate agitation methods, such as those generating excessive foam or vortices, can exert real forces of mechanical shear on antigen-antibody complexes with weaker bindings (greater K<sub>D</sub>, less negative &#x394;<italic>G</italic> or relatively greater k<sub>off</sub>). This may increase energy and loosen feeder lines that produce some bound-specific antibodies and decrease outputs (<xref ref-type="bibr" rid="B41">Shieh and Patel, 2015</xref>).</p>
</sec>
<sec id="s2-8">
<title>Blocking</title>
<p>The purpose of blocking is to enhance the specificity of subsequent immunodetection by occupying non-specific binding sites on the membrane (<xref ref-type="bibr" rid="B15">Kothari and Mathews, 2015</xref>). Ideal blocking agents, such as BSA or skim milk powder, effectively bind to vacant areas on PVDF or NC membranes that may otherwise engage in hydrophobic or electrostatic interactions with antibodies (<xref ref-type="bibr" rid="B15">Kothari and Mathews, 2015</xref>). This forms an inert protein layer, which makes &#x394;<italic>G</italic> for non-specific interactions between antibodies and the blocked regions highly unfavorable. In another word, the K<sub>D</sub> value for these sites becomes extremely large for the detecting antibody, thereby significantly reducing background interference (<xref ref-type="bibr" rid="B39">Schwartz and Bochkariov, 2017</xref>). This beneficial blocking effect originates from the strong interaction of blocking molecules with the membrane surface (negative &#x394;<italic>G</italic>), and the &#x201c;repulsive&#x201d; or at least &#x201c;neutral&#x201d; surface characteristics of the blocking layer for antibodies.</p>
<p>However, excessive blocking (e.g., excessively high concentration of blocking agents, excessively long blocking time, or inherent unexpected properties of the blocking agents) can lead to unfavorable outcomes (<xref ref-type="bibr" rid="B15">Kothari and Mathews, 2015</xref>). Blocking agents with extremely high concentration or excessively large size may not merely remain on &#x2018;blank&#x2019; regions. Through non-specific adsorption or intermolecular stacking, such blocking agents may partly or even completely mask or encapsulate target antigens already immobilized on the membrane. This physical masking significantly increases the steric hindrance for the primary antibody, which should bind to the target antigen epitope, thereby increasing the activation energy needed for specific antigen-antibody binding. This can render an inherently favorable binding &#x394;<italic>G</italic> (e.g., a highly negative &#x394;<italic>G</italic> for specific binding). It can be less favorable due to the need to overcome an additional energy barrier, or can be kinetically very slow (significantly reduced k<sub>on</sub>). Blocking agents with weak and non-specific attractive forces with the target antigen can transiently or weakly bind to the target antigen in the presence of excessive blocking. These weak interactions may perturb the optimal binding conformation between the primary antibody and the target antigen or partly occupy certain regions of the antigen epitope. This can increase the effective K<sub>D</sub> value for the primary antibody binding to the target antigen (reduced affinity), with a less negative &#x394;<italic>G</italic> and a diminished specific signal. Excessively high concentrations of blocking agents (especially certain proteins like casein) can form aggregates under specific conditions. Due to their physicochemical properties (e.g., hydrophobicity, charge), these aggregates may non-specifically deposit on the membrane, potentially encapsulating some antibodies and introducing new background signals or interfering with the uniform diffusion of subsequent reagents.</p>
</sec>
<sec id="s2-9">
<title>Washing</title>
<p>The specific and high-affinity binding of antigen to the antibody is characterized by a high negative &#x394;<italic>G</italic> value with a low K<sub>D</sub> value, forming very stable complexes. On the contrary, low-specific or non-specific binding is characterized by a less negative &#x394;<italic>G</italic> (possibly near zero or slightly positive) along with a higher K<sub>D</sub> and a relatively fast k<sub>off</sub> rate, leading to the formation of unstable complexes that dissociate rapidly. Sufficient washing with the continuous flow of fresh wash buffer removes free antibodies from the solution. Based on Le Chatelier&#x2019;s principle, washing removes loosely bound non-specific molecules that are in rapid association-dissociation dynamic equilibrium (<xref ref-type="bibr" rid="B50">Yukhananov et al., 2022</xref>). Detergents in the wash buffer, such as Tween-20, effectively reduce the strength of non-specific hydrophobic interactions by altering their &#x394;<italic>H</italic> and &#x394;<italic>S</italic>, thus rendering their binding &#x394;<italic>G</italic> less favorable. Therefore, detergents promote their dissociation from the immobilized target (<xref ref-type="bibr" rid="B50">Yukhananov et al., 2022</xref>). Such actions reduce the background signal, thus emphasizing a signal generated specifically by stable complexes and enhancing the signal-to-noise ratio and specificity of detection (<xref ref-type="bibr" rid="B50">Yukhananov et al., 2022</xref>; <xref ref-type="bibr" rid="B26">Norris et al., 2005</xref>).</p>
<p>However, some specific signals will be lost in case of too harsh or prolonged wash. In specific binding, when the affinity is not very high (e.g., K<sub>D</sub> is in the intermediate range, &#x394;<italic>G</italic> is not significantly negative or k<sub>off</sub> is small but not negligible), prolonged or high-stringency washing (e.g., in the presence of high detergent concentration, high ionic strength, and temperature) may dissociate the specific complexes and reduce the target signal. Such situations tend to be more evident in the detection of low-abundance target proteins or antibodies with moderate affinity.</p>
</sec>
<sec id="s2-10">
<title>pH value</title>
<p>pH alters the ionization state and conformation of protein molecules (antigens, antibodies, and blocking agents) (<xref ref-type="bibr" rid="B4">Devanaboyina et al., 2013</xref>). The binding &#x394;<italic>H</italic> (electrostatic interactions and hydrogen bonds) and &#x394;<italic>S</italic> (conformational entropy and solvation entropy) are directly associated with the effects of pH. Each protein has an isoelectric point, which relies on pH and controls the protonation state of amino acid residues on the protein surface (e.g., lysine, arginine, glutamate, aspartate, and histidine), thereby determining the net charge and local charge distribution of proteins (<xref ref-type="bibr" rid="B4">Devanaboyina et al., 2013</xref>; <xref ref-type="bibr" rid="B5">Endo et al., 1987</xref>). Antigen-antibody interactions usually occur based on specific charge complementarity (electrostatic interaction favors, hence making &#x394;<italic>H</italic> more negative) and an extensive hydrogen bond network. An optimal pH (usually close to physiological pH 7.0&#x2013;7.4) can maintain the epitope of the antigen and the CDRs of the antibody in a state of ionization and configuration that is most favorable for interaction and can increase the binding affinity (i.e., most negative &#x394;<italic>G</italic>, least K<sub>D</sub>) (<xref ref-type="bibr" rid="B4">Devanaboyina et al., 2013</xref>; <xref ref-type="bibr" rid="B11">Igawa et al., 2010</xref>). An appropriate pH is essential for preserving the structural integrity and biological activity of antibodies, especially enzyme-conjugated secondary antibodies, while an extreme pH value can prevent their denaturation and inactivation.</p>
<p>Buffer pH out of the optimal range for a given pair of antigen-antibodies can lead to various adverse situations. First, any alterations in the surface charge of proteins can interfere with existing electrostatic attractions or form electrostatic repulsions, weaken hydrogen bonding, or even induce conformational changes in important residues in the antigen epitope or in the CDRs of the antibody (<xref ref-type="bibr" rid="B4">Devanaboyina et al., 2013</xref>; <xref ref-type="bibr" rid="B5">Endo et al., 1987</xref>). All of these changes make &#x394;<italic>H</italic> and &#x394;<italic>S</italic> less favorable for specific binding (e.g., changes in conformational entropy), thus leading to a less negative or even positive &#x394;<italic>G</italic> and reducing affinity (increase in K<sub>D</sub>) or signal (<xref ref-type="bibr" rid="B11">Igawa et al., 2010</xref>). Secondly, acidic or alkaline pH values can lead to irreversible protein denaturation and a total loss of binding. Besides, any change in pH will alter the surface charge on the membrane or blocking agents, which will then unintentionally increase certain non-specific electrostatic adsorptions and result in a high background (<xref ref-type="bibr" rid="B36">Ruiz et al., 2019</xref>). For example, when the membrane is negatively charged and the antibody is positively charged, the &#x394;<italic>G</italic> can be favorable for non-specific adsorption via electrostatics.</p>
</sec>
<sec id="s2-11">
<title>Ionic strength</title>
<p>The ionic strength is the primary modulator of electrostatic and hydrophobic interactions between proteins, which screens the charges and the hydration layers, thereby modulating the binding &#x394;<italic>H</italic> and &#x394;<italic>S</italic> (<xref ref-type="bibr" rid="B38">Sah et al., 2010</xref>). Thus, in the buffer, the salt ions Na<sup>&#x2b;</sup> and Cl<sup>&#x2212;</sup> (such as from NaCl) can effectively screen the electrostatic charges on the protein surface (<xref ref-type="bibr" rid="B13">Kamata et al., 1996</xref>). A modest increase in ionic strength reduces these long-range electrostatic forces via the salt-screening effect for background binding, which is mainly mediated by non-specific electrostatic attraction between antibodies and oppositely charged membrane surfaces or contaminating proteins (<xref ref-type="bibr" rid="B13">Kamata et al., 1996</xref>; <xref ref-type="bibr" rid="B32">Pisetsky et al., 2021</xref>). A modest increase in ionic strength will also decrease background non-specificity, leading to a less favorable &#x394;<italic>H</italic> contribution to &#x394;<italic>G</italic> for such non-specific interactions. In addition, certain ionic strength levels are also needed for protein native conformation and solubility, a factor also contributing to the stability of antibodies (<xref ref-type="bibr" rid="B31">Pindrus et al., 2018</xref>).</p>
<p>On the other hand, too high ionic strength can weaken not only non-specific electrostatic interactions but also electrostatic attractions or perfect salt bridge structures that bear on specific antigen-antibody binding (<xref ref-type="bibr" rid="B13">Kamata et al., 1996</xref>; <xref ref-type="bibr" rid="B35">Roy et al., 1999</xref>). If specific binding mainly relies on electrostatic interactions that yield a positive &#x394;<italic>H</italic>, a very high ionic strength will reduce that contribution, yielding a less negative &#x394;<italic>G</italic>, less binding energy (greater K<sub>D</sub>), and less signal (<xref ref-type="bibr" rid="B35">Roy et al., 1999</xref>). Typically, high salt concentrations (the &#x201c;salting-out effect&#x201d;) strengthen hydrophobic interactions. An ionic salt competes with water for hydration, forcing non-polar surfaces to aggregate and minimize their contact area with water, thereby producing greater solvent entropy &#x394;<italic>S</italic>, and more negative &#x394;<italic>G</italic> (<xref ref-type="bibr" rid="B17">Kumar et al., 2011</xref>). In some cases, this may accentuate specific hydrophobic binding but also augment non-specific hydrophobic adsorption, leading to increased background (<xref ref-type="bibr" rid="B45">Thompson et al., 2016</xref>). Very low ionic strength, on the other hand, not only screens off non-specific electrostatic interactions but also decreases the solubility or aggregation of certain proteins (<xref ref-type="bibr" rid="B31">Pindrus et al., 2018</xref>; <xref ref-type="bibr" rid="B20">Liu et al., 2023</xref>).</p>
</sec>
</sec>
<sec id="s3">
<title>Explaining common experimental issues of western blotting from a thermodynamic and kinetic perspective</title>
<sec id="s3-1">
<title>No signal or weak signal</title>
<p>A lack of signal or signal intensity observed in Western blotting indicates that the formation of a measurable amount of stable specific antigen-antibody complexes was somehow impaired or the formed complexes did not efficiently convert into a measurable signal (<xref ref-type="bibr" rid="B6">Garc&#xed;a-S&#xe1;nchez et al., 2023</xref>). Thermodynamically, Western blotting with no signal usually signifies either that the &#x394;<italic>G</italic> for specific binding is not negative enough (i.e., low affinity and high K<sub>D</sub> value) or is positive, suggesting that binding is non-spontaneous. Such apparent interactions may be affected by inadequate antibody concentration (inactivation), degradation of the target antigen, or masking of the epitopic sites, hence preventing precise non-covalent interactions (contributing a favorable &#x394;<italic>H</italic>) and conformational complementarity (contributing an unfavorable &#x394;<italic>S</italic>) (<xref ref-type="bibr" rid="B6">Garc&#xed;a-S&#xe1;nchez et al., 2023</xref>; <xref ref-type="bibr" rid="B20">Liu et al., 2023</xref>). Translating into kinetics, a too-slow association rate constant (k<sub>on</sub>) owing to excessively low antibody concentration, a short incubation time, or a low temperature that inhibits molecular thermal motion and reduces the collision frequency of antibodies with target proteins, or hindered diffusion and excessive dissociation rate constant (k<sub>off</sub>) may prevent complex formation (<xref ref-type="bibr" rid="B20">Liu et al., 2023</xref>). Finally, enzyme inactivation and substrate failure in the downstream detection system can also prevent signal generation (<xref ref-type="bibr" rid="B51">Zhou et al., 2021</xref>).</p>
</sec>
<sec id="s3-2">
<title>High background</title>
<p>High backgrounds in Western blotting primarily arise from the binding of a detecting antibody to a large area of non-target molecules in the membrane, or even to the membrane itself (<xref ref-type="bibr" rid="B9">Grainger et al., 2014</xref>). These non-specific adsorption events correspond to negative &#x394;<italic>G</italic>, but most time, not as favorable as specific binding. Such events are mostly caused by low or inadequate blocking, leaving many hydrophobic or charged surfaces on the membrane exposed, which can then specifically bind to antibody molecules through hydrophobic effects (yielding favorable &#x394;<italic>S</italic> and/or &#x394;<italic>H</italic>) or electrostatic attraction (offering favorable &#x394;<italic>H</italic>) for non-specific binding (<xref ref-type="bibr" rid="B6">Garc&#xed;a-S&#xe1;nchez et al., 2023</xref>; <xref ref-type="bibr" rid="B9">Grainger et al., 2014</xref>). Extremely high concentrations of an antibody will increase the collisional frequency among species, thereby leading to the accumulation of small-affinity (large K<sub>D</sub>, less negative &#x394;<italic>G</italic>) non-specific interactions. Poor washing does not take full advantage of the larger k<sub>off</sub> values of non-specific bindings to achieve their release through thermal motion and concentration gradients (<xref ref-type="bibr" rid="B6">Garc&#xed;a-S&#xe1;nchez et al., 2023</xref>).</p>
</sec>
<sec id="s3-3">
<title>Non-specific bands</title>
<p>The presence of so-called non-specific bands indicates that the primary antibody (or, indirectly, the secondary antibody) has established an affinity-driven binding with other proteins in the sample, with a different molecule compared to the target protein (<xref ref-type="bibr" rid="B25">Nakashima et al., 2019</xref>). These &#x201c;erroneous&#x201d; binding events are associated with a negative &#x394;<italic>G</italic>, although usually with a K<sub>D</sub> larger than the antibody&#x2019;s binding to the primary target. It primarily accounts for antibody cross-reactivity that recognizes similar-epitope non-target proteins. Specifically, structural similarity allows the formation of partially favorable non-covalent bonds, with &#x394;<italic>H</italic> and &#x394;<italic>S</italic> contributions leading to negative &#x394;<italic>G</italic> (<xref ref-type="bibr" rid="B30">Perween et al., 2021</xref>). Similarly, degraded products of the target protein provide their epitopes for antibody recognition, forming additional bands (<xref ref-type="bibr" rid="B25">Nakashima et al., 2019</xref>). Increased concentration of the antibody beyond certain limits can increase the chance of binding to these degraded products with lesser affinities. Both incomplete blockade or too gentle washing may allow cross-reactive binding events, whose strength is between strong specific binding and very weak non-specific adsorption (<xref ref-type="bibr" rid="B25">Nakashima et al., 2019</xref>).</p>
</sec>
<sec id="s3-4">
<title>Uneven bands and poor reproducibility</title>
<p>Miscalibrated conditions or discrepancies in the experiments lead to the emergence of uneven bands or irreproducible results in Western blotting (<xref ref-type="bibr" rid="B6">Garc&#xed;a-S&#xe1;nchez et al., 2023</xref>; <xref ref-type="bibr" rid="B30">Perween et al., 2021</xref>). Therefore, there are many uncontrolled conditions, such as thermal motion, diffusion rates, kinetic reaction rates, and even chemical thermodynamics. For example, differences caused by poor electrophoresis or transfer of proteins (gel defects, air bubbles, and uneven pressure) can occur in the initial distribution of the antigen (<xref ref-type="bibr" rid="B24">Mishra et al., 2017</xref>; <xref ref-type="bibr" rid="B7">Gari&#x107; et al., 2023</xref>). Insufficient washing or drying of the membrane directly affects the incidence frequencies and concentrations in the local context of collision. Non-exact control or fluctuation in temperature, pH, and ionic strength directly affects energies (&#x394;<italic>H</italic>, &#x394;<italic>S</italic>, and &#x394;<italic>G</italic>) and rates of all molecular associations, which results in differences in binding efficiency or final signal intensity (<xref ref-type="bibr" rid="B24">Mishra et al., 2017</xref>). Small technical changes can lead to noticeable differences in results via variations in molecular thermal motion, diffusion rates, chemical reaction kinetics, and molecular interaction.</p>
</sec>
<sec id="s3-5">
<title>Troubleshooting based on the new framework</title>
<p>Traditional troubleshooting in Western blotting often relies on empirical &#x201c;trial-and-error&#x201d; methods. However, our proposed framework, based on thermodynamics and molecular thermal motion, aims to promote troubleshooting from an &#x201c;empirical mode&#x201d; to a &#x201c;principle-driven mode.&#x201d; The core diagnostic premise is that any issue in Western blotting, whether related to signal intensity or specificity, can be attributed to an imbalance in thermodynamic parameters (favorability of &#x394;<italic>G</italic>, reflecting affinity K<sub>D</sub>) and kinetic parameters (relative magnitudes of association rate constant kon and dissociation rate constant k<sub>off</sub> of the interactions between target molecules and non-target molecules. Troubleshooting thus necessitates adjusting experimental conditions to achieve the favorable &#x394;<italic>G</italic> and appropriate kinetic rates for specific binding, while simultaneously minimizing the &#x394;<italic>G</italic> for non-specific binding or accelerating its dissociation.</p>
</sec>
<sec id="s3-6">
<title>Teaching application example: coexistence of weak signal and high background</title>
<p>To provide an example of how this framework can help teaching, we analyze a scenario that commonly occurs. A student reports a Western blotting where the target band is very weak or absent but where there is generally a very high background over the whole membrane. An instructor expert in thermodynamics and molecular thermal motion can guide the students&#x2019; thinking:</p>
<p>Teacher says: &#x201c;Let&#x2019;s analyze these results. We have two primary issues: weak specific signal and high non-specific noise. From the framework we have studied, what might a weak specific signal imply thermodynamically and kinetically about antigen-antibody interaction?&#x201d;</p>
<p>Student (guided): &#x201c;This could suggest that &#x394;G associated with specific binding is not sufficiently negative, suggesting low affinity (high KD value), which can lead to the formation of very few stable complexes. Alternatively, the antibody concentration can be too low, with a reasonable KD, where mass action law suggests insufficient Ag-Ab complexes. Kinetically, perhaps the incubation time was not enough, and the antibody molecules did not have enough effective collisions with antigen via Brownian motion. Therefore, the reaction never attained equilibrium (kon-related events were simply too little), or the incubation temperature was too low, which decreased molecular motion rate and made kon too small.&#x201d;</p>
<p>Teacher: &#x201c;Excellent. Now, what about the high background? How does our framework explain antibodies non-specifically adsorbing across the membrane?&#x201d;</p>
<p>Student (guided): &#x201c;The binding of antibodies to non-specific sites on the membrane might be favorable thermodynamically (negative &#x394;<italic>G</italic>), or at least not sufficiently unfavorable (&#x394;<italic>G</italic> close to zero). Probably, our blocking step did not effectively provide enough energy barrier for subsequent antibody adsorption to these non-specific sites (i.e., it failed to make the &#x394;<italic>G</italic> for these non-specific interactions more positive or significantly less negative than for specific binding). Additionally, when the antibody concentration is very high, the sheer number of random collisions between antibodies and the membrane, driven by molecular thermal motion, can lead to non-specific antibody adsorption, even when the &#x201c;binding energy&#x201d; of a single non-specific adsorption event (corresponding to -&#x394;<italic>G</italic>) is very low due to cumulative effects.&#x201d;</p>
<p>Teacher: &#x201c;Very well. Then that leaves us with another question: how an extremely high concentration of primary antibody may lead to a not-so-specific signal and an excessive background signal?&#x201d;</p>
<p>Student (guided): &#x201c;Principally, high concentration increases collision frequency enough to maximize the site-specific element. Too much concentration will unbalance excess collisions and binding opportunities with other sites with only slightly lower affinity and cause this much higher background. It will also simultaneously dilute the effective concentration of an antibody that can reach the target antigens and may bind to the weakly non-specific sites. The antibody itself tends toward aggregation by promoting this non-specific adsorption.&#x201d;</p>
<p>Teacher: &#x201c;From here, what steps seem logically the first steps for troubleshooting? And what is the rationale behind each step from the perspective of &#x394;<italic>G</italic>, K<sub>D</sub>, concentration, and molecular interactions like K<sub>on</sub> and K<sub>off</sub>?&#x201d;</p>
<p>Student (guided): &#x201c;First, optimize primary antibody concentration-gradient dilutions to find a concentration suitable for achieving specific binding. This concentration provides sufficient negative &#x394;<italic>G</italic> for Ag-Ab formation with enough molecules participating in the reaction but prevents non-specific binding by reducing non-specific collisions and weakening the total &#x394;<italic>G</italic> of non-specific binding. In essence, this strategy relies on number adjustment for the reacting molecules, which can balance the kinetics and final equilibrium of specific-non-specific interactions. Second, changing the blocking agents raises the concentration of the current blocking agent and extends the blocking time. This strategy ensures that non-specific binding sites on the membrane are thoroughly occupied, thus rendering conditions thermodynamically very unfavorable (positive values). Third, increasing the number of washes, prolonging individual wash times, or increasing the concentration of detergents in the wash buffer (e.g., Tween-20). In non-specific binding, these complexes are less stable (have larger k<sub>offs</sub>) and their &#x394;<italic>G</italic> is less negative. Adequate washes will remove free antibodies and provide energy and time for the dissociation of loosely bound non-specific molecules that are in a fast <italic>versus</italic> slow association-dissociation dynamic equilibrium. This strategy can overcome the energy barrier for dissociation and induce thermal motion among molecules.&#x201d;</p>
</sec>
<sec id="s3-7">
<title>Advantages and challenges of this teaching framework</title>
<p>The primary advantage of this framework is its potential to transform Western blotting instruction from a simple &#x201c;hands-on&#x201d; procedural exercise into a rich &#x201c;minds-on&#x201d; experience that fosters true &#x201c;scientific reasoning. Understanding &#x201c;why&#x201d; something is done with each experimental procedure (rather than simply memorizing experimental steps) grounds students with a practical understanding of molecular interaction energies (&#x394;<italic>G</italic>, &#x394;<italic>H</italic>, &#x394;<italic>S</italic>) and rates (k<sub>on</sub>, k<sub>off</sub>). By doing so, this paves the way for the development of a rational, systematic troubleshooting mindset, enhancing efficiency and innovation in solving experimental problems, compared with blind trial and error. More importantly, this approach can increase students&#x2019; motivation to learn, foster confidence in research, and encourage independent thinking and new problem-solving skills because a coherent explanatory framework is used to traverse an otherwise highly complex experiment.</p>
<p>While integrating thermodynamics and molecular thermal motion principles into the teaching of Western blotting has tangible benefits, certain obstacles arise in their utilization. Firstly, students often have limited knowledge of chemical thermodynamics and kinetics, making it difficult for them to understand the role of biophysical concepts, such as &#x394;<italic>G</italic>, &#x394;<italic>H</italic>, &#x394;<italic>S</italic>, k<sub>on</sub>, and k<sub>off</sub>, in regulating antigen-antibody interactions. The introduction of simplified preparatory materials before the experiment, with the help of metaphors and visualization aids (e.g., animations of molecular motions and binding processes), can lower the cognitive load on students. The learning process can also be more effective by emphasizing conceptual understanding rather than intricate mathematical derivations. Besides, this teaching approach puts higher demands on instructors. In addition to having a strong personal understanding of these principles, instructors should teach the abstract theory associated with experiential knowledge and conduct inquiry-based learning. This point can be facilitated through specific faculty training, the development of full teaching case studies and standardized sets of guiding questions, and encouraging people to share their experiences in this regard. Thirdly, it will put pressure on curriculum design and time allocation to offer experimental training and full and deep biophysical discussion in a limited time. A flipped classroom wherein students learn about theoretical concepts before classes, and then proceed with application and discussion and problem-solving in the classroom may be an optimal strategy in this regard. Alternatively, we can incorporate principle-based teaching into the explanations of each operational step rather than confining it to discrete theoretical instructional modules. Finally, assessing whether students can also apply this strategy flexibly to solve new problems is far more complicated than operational assessment alone. Educators must develop more summative assessment tasks in students&#x2019; troubleshooting plan design in which students must provide an extended and in-depth interpretation of the experimental results based on principles rather than through conventional lab reports.</p>
</sec>
</sec>
<sec id="s4">
<title>Conclusion and outlook</title>
<p>Western blotting will remain the main method of detection in the field of immunology and molecular biology. Hence, understanding its underlying principles has become an eminent educational objective for students. The thermodynamic and molecular thermal motion framework explained in this report offers a powerful and comprehensive approach surpassing purely mechanical-operational teaching. By viewing the immunodetection process as a dynamic interplay of molecular forces, affinities, and motion, students can acquire a deeper understanding of more effective troubleshooting, optimal experimental designs, and more critical scientific reasoning.</p>
<p>While the framework presented offers a powerful conceptual tool, future empirical studies will be indispensable for fully assessing its influence on student learning outcomes and their ability to troubleshoot experiments effectively. Future research will therefore incorporate the design and implementation of a quasi-experimental study that compares student cohorts. One cohort would receive traditional instruction and the other would be instructed using our thermodynamic and kinetic framework. This study would implement pre- and post-test components, conceptual inventory questionnaires, and performance-based assessments (e.g., analyzing mock troubleshooting scenarios) to quantify gains in declarative knowledge and practical problem-solving skills. Qualitative input on student engagement and perceived learning value will also be collated through surveys and focus groups.</p>
<p>Looking forward, the fundamental ideas of this framework will find their way into teaching other techniques, such as ELISA, immunoprecipitation, and immunofluorescence, that rely on specific biomolecular recognition. Therefore, we believe that this manuscript, as a well-defined pedagogical proposal, serves as a valuable and immediately applicable resource for educators, providing them with a solid conceptual blueprint to move beyond rote memorization and build a more robust and transferable scientific reasoning ability in their students.</p>
</sec>
</body>
<back>
<sec sec-type="author-contributions" id="s5">
<title>Author contributions</title>
<p>ZW: Writing &#x2013; original draft. MW: Writing &#x2013; review and editing. YY: Writing &#x2013; review and editing. YL: Writing &#x2013; review and editing. QX: Writing &#x2013; review and editing. PW: Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s6">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. The present research was supported by the Teaching Reform Project of Zunyi Medical University (Nos 2021Z07, ZH202113, and ZH202201B), and the Key Construction Discipline of Immunology and Pathogen biology in Zhuhai Campus of Zunyi Medical University (ZHGF2024-1).</p>
</sec>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s8">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Algen&#xe4;s</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Agaton</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fagerberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Asplund</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bj&#xf6;rling</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bj&#xf6;rling</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Antibody performance in Western blot applications is context-dependent</article-title>. <source>Biotechnol. J.</source> <volume>9</volume> (<issue>3</issue>), <fpage>435</fpage>&#x2013;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1002/biot.201300341</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Begum</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Murugesan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tangutur</surname>
<given-names>A. D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Western blotting: a powerful staple in scientific and biomedical research</article-title>. <source>Biotechniques</source> <volume>73</volume> (<issue>1</issue>), <fpage>58</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.2144/btn-2022-0003</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butler</surname>
<given-names>T. A. J.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tolosa</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Misleading westerns: common quantification mistakes in Western blot densitometry and proposed corrective measures</article-title>. <source>Biomed. Res. Int.</source> <volume>2019</volume>, <fpage>5214821</fpage>. <pub-id pub-id-type="doi">10.1155/2019/5214821</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devanaboyina</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Ober</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Ram</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Puig-Canto</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics</article-title>. <source>MAbs</source> <volume>5</volume> (<issue>6</issue>), <fpage>851</fpage>&#x2013;<lpage>859</lpage>. <pub-id pub-id-type="doi">10.4161/mabs.26389</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Endo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Miyai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Iijima</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Effect of pH on antigen binding by clonotypic antibodies with different isoelectric points</article-title>. <source>Biotechnol. Appl. Biochem.</source> <volume>9</volume> (<issue>1</issue>), <fpage>74</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1111/j.1470-8744.1987.tb00464.x</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garc&#xed;a-S&#xe1;nchez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Faro</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>B cell receptors and free antibodies have different antigen-binding kinetics</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>120</volume> (<issue>35</issue>), <fpage>e2220669120</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2220669120</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gari&#x107;</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dumut</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Centorame</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Radzioch</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Western blotting with fast SDS&#x2010;PAGE and semi&#x2010;dry protein transfer</article-title>. <source>Curr. Protoc.</source> <volume>3</volume> (<issue>7</issue>), <fpage>e833</fpage>. <pub-id pub-id-type="doi">10.1002/cpz1.833</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilda</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cheah</surname>
<given-names>J. X.</given-names>
</name>
<name>
<surname>West</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Bodine</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Western blotting inaccuracies with unverified antibodies: need for a Western blotting minimal reporting standard (WBMRS)</article-title>. <source>PLoS One</source> <volume>10</volume> (<issue>8</issue>), <fpage>e0135392</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0135392</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grainger</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Ban</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Cleaning up Western Blot signals from immunoprecipitated samples using alternative detection methods</article-title>. <source>Biotechniques</source> <volume>56</volume> (<issue>3</issue>), <fpage>149</fpage>&#x2013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.2144/000114149</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Modeling micropatterned antigen-antibody binding kinetics in a microfluidic chip</article-title>. <source>Biosens. Bioelectron.</source> <volume>22</volume> (<issue>7</issue>), <fpage>1403</fpage>&#x2013;<lpage>1409</lpage>. <pub-id pub-id-type="doi">10.1016/j.bios.2006.06.017</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Igawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tachibana</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Higuchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shimaoka</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization</article-title>. <source>Nat. Biotechnol.</source> <volume>28</volume> (<issue>11</issue>), <fpage>1203</fpage>&#x2013;<lpage>1207</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1691</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnstone</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Andrew</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Hogarth</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Pietersz</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>I. F.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>The effect of temperature on the binding kinetics and equilibrium constants of monoclonal antibodies to cell surface antigens</article-title>. <source>Mol. Immunol.</source> <volume>27</volume> (<issue>4</issue>), <fpage>327</fpage>&#x2013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1016/0161-5890(90)90045-2</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Enomoto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kurisaki</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kaminogawa</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Comparison of pH and ionic strength dependence of interactions between monoclonal antibodies and bovine beta-lactoglobulin</article-title>. <source>Biosci. Biotechnol. Biochem.</source> <volume>60</volume> (<issue>1</issue>), <fpage>25</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.60.25</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Barrette</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bouhaddou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Azeloglu</surname>
<given-names>E. U.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Validating antibodies for quantitative Western Blot measurements with microwestern array</article-title>. <source>Sci. Rep.</source> <volume>8</volume> (<issue>1</issue>), <fpage>11329</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-29436-0</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kothari</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>S. T.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Detection of blotted proteins: not all blockers are created equal</article-title>. <source>Methods Mol. Biol.</source> <volume>1314</volume>, <fpage>27</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-2718-0_4</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Breuer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Akan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>E. A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Blind spots on western blots: assessment of common problems in western blot figures and methods reporting with recommendations to improve them</article-title>. <source>PLoS Biol.</source> <volume>20</volume> (<issue>9</issue>), <fpage>e3001783</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.3001783</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Dixit</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fraunhofer</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Impact of short range hydrophobic interactions and long range electrostatic forces on the aggregation kinetics of a monoclonal antibody and a dual-variable domain immunoglobulin at low and high concentrations</article-title>. <source>Int. J. Pharm.</source> <volume>421</volume> (<issue>1</issue>), <fpage>82</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2011.09.017</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levison</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Jancsi</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Dandliker</surname>
<given-names>W. B.</given-names>
</name>
</person-group> (<year>1968</year>). <article-title>Temperature effects on the kinetics of the primary antigen-antibody combination</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>33</volume> (<issue>6</issue>), <fpage>942</fpage>&#x2013;<lpage>948</lpage>. <pub-id pub-id-type="doi">10.1016/0006-291x(68)90403-8</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z. Q.</given-names>
</name>
<name>
<surname>Mahmood</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P. C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Western Blot: technique, theory and trouble shooting</article-title>. <source>N. Am. J. Med. Sci.</source> <volume>6</volume> (<issue>3</issue>), <fpage>160</fpage>. <pub-id pub-id-type="doi">10.4103/1947-2714.128482</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Comprehensive optimization of Western blotting</article-title>. <source>Gels</source> <volume>9</volume> (<issue>8</issue>), <fpage>652</fpage>. <pub-id pub-id-type="doi">10.3390/gels9080652</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loeffler</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Klaver</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Polyvalent immunoglobulin binding is an obstacle to accurate measurement of specific antibodies with ELISA despite inclusion of blocking agents</article-title>. <source>Int. Immunopharmacol.</source> <volume>52</volume>, <fpage>227</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2017.09.016</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mason</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>A. F.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>The kinetics of antibody binding to membrane antigens in solution and at the cell surface</article-title>. <source>Biochem. J.</source> <volume>187</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1042/bj1870001</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meftahi</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Bahari</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zarei Mahmoudabadi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jangravi</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Applications of western blot technique: from bench to bedside</article-title>. <source>Biochem. Mol. Biol. Educ.</source> <volume>49</volume> (<issue>4</issue>), <fpage>509</fpage>&#x2013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1002/bmb.21516</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Protein purification and analysis: next generation Western blotting techniques</article-title>. <source>Expert Rev. Proteomics</source> <volume>14</volume> (<issue>11</issue>), <fpage>1037</fpage>&#x2013;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1080/14789450.2017.1388167</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakashima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Iwashita</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kohno</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kamei</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A spatial similarity of stereochemical environments formed by amino acid residues defines a common epitope of two non-homologous proteins</article-title>. <source>Sci. Rep.</source> <volume>9</volume> (<issue>1</issue>), <fpage>14818</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-51350-2</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norris</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Caprioli</surname>
<given-names>R. M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Combination detergent/MALDI matrix: functional cleavable detergents for mass spectrometry</article-title>. <source>Anal. Chem.</source> <volume>77</volume> (<issue>15</issue>), <fpage>5036</fpage>&#x2013;<lpage>5040</lpage>. <pub-id pub-id-type="doi">10.1021/ac050460g</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nygren</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stenberg</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Kinetics of antibody-binding to surface-immobilized antigen: influence of mass transport on the enzyme-linked immunosorbent assay (ELISA)</article-title>. <source>J. Colloid Interface Sci.</source> <volume>107</volume> (<issue>2</issue>), <fpage>560</fpage>&#x2013;<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9797(85)90209-7</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perchiacca</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Tessier</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Engineering aggregation-resistant antibodies</article-title>. <source>Annu. Rev. Chem. Biomol. Eng.</source> <volume>3</volume>, <fpage>263</fpage>&#x2013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-chembioeng-062011-081052</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereiro</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fomitcheva-Khartchenko</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaigala</surname>
<given-names>G. V.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Shake it or shrink it: mass transport and kinetics in surface bioassays using agitation and microfluidics</article-title>. <source>Anal. Chem.</source> <volume>92</volume> (<issue>15</issue>), <fpage>10187</fpage>&#x2013;<lpage>10195</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.0c01625</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perween</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>PraveenKumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shrivastava</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Parray</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41</article-title>. <source>Int. Immunopharmacol.</source> <volume>101</volume> (<issue>Pt B</issue>), <fpage>108187</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2021.108187</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pindrus</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Shire</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kalonia</surname>
<given-names>D. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The effect of low ionic strength on diffusion and viscosity of monoclonal antibodies</article-title>. <source>Mol. Pharm.</source> <volume>15</volume> (<issue>8</issue>), <fpage>3133</fpage>&#x2013;<lpage>3142</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.8b00210</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pisetsky</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The interaction of anti-DNA antibodies with DNA antigen: evidence for hysteresis for high avidity binding</article-title>. <source>Clin. Immunol.</source> <volume>231</volume>, <fpage>108848</fpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2021.108848</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rathaur</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Panigrahi</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Panda</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Investigating the effect of antibody-antigen reactions on the internal convection in a sessile droplet <italic>via</italic> micro particle image velocimetry and DLVO analysis</article-title>. <source>Langmuir</source> <volume>36</volume> (<issue>30</issue>), <fpage>8826</fpage>&#x2013;<lpage>8838</lpage>. <pub-id pub-id-type="doi">10.1021/acs.langmuir.0c01162</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dimitrov</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Evaluation of binding kinetics and thermodynamics of antibody-antigen interactions and interactions involving complement proteins</article-title>. <source>Methods Mol. Biol.</source> <volume>2227</volume>, <fpage>237</fpage>&#x2013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-0716-1016-9_21</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Margolies</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Yarmush</surname>
<given-names>M. L.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Effect of pressure on antigen-antibody complexes: modulation by temperature and ionic strength</article-title>. <source>Mol. Immunol.</source> <volume>36</volume> (<issue>17</issue>), <fpage>1149</fpage>&#x2013;<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.1016/S0161-5890(99)00133-9</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okyem</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Driskell</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>pH impacts the orientation of antibody adsorbed onto gold nanoparticles</article-title>. <source>Bioconjug Chem.</source> <volume>30</volume> (<issue>4</issue>), <fpage>1182</fpage>&#x2013;<lpage>1191</lpage>. <pub-id pub-id-type="doi">10.1021/acs.bioconjchem.9b00123</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sagawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ishimura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Azuma</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Thermodynamic and kinetic aspects of antibody evolution during the immune response to hapten</article-title>. <source>Mol. Immunol.</source> <volume>39</volume> (<issue>13</issue>), <fpage>801</fpage>&#x2013;<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1016/s0161-5890(02)00282-1</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Grillo</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Perkins</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies</article-title>. <source>J. Pharm. Sci.</source> <volume>99</volume> (<issue>12</issue>), <fpage>4830</fpage>&#x2013;<lpage>4848</lpage>. <pub-id pub-id-type="doi">10.1002/jps.22198</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bochkariov</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Novel chemiluminescent Western blot blocking and antibody incubation solution for enhanced antibody&#x2010;antigen interaction and increased specificity</article-title>. <source>Electrophoresis</source> <volume>38</volume> (<issue>20</issue>), <fpage>2631</fpage>&#x2013;<lpage>2637</lpage>. <pub-id pub-id-type="doi">10.1002/elps.201700143</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>F. P.</given-names>
</name>
<name>
<surname>Tello</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Goldbaum</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Mariuzza</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Poljak</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Thermodynamics of antigen-antibody binding using specific anti-lysozyme antibodies</article-title>. <source>Eur. J. Biochem.</source> <volume>228</volume> (<issue>2</issue>), <fpage>388</fpage>&#x2013;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.0388n.x</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shieh</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Predicting the agitation-induced aggregation of monoclonal antibodies using surface tensiometry</article-title>. <source>Mol. Pharm.</source> <volume>12</volume> (<issue>9</issue>), <fpage>3184</fpage>&#x2013;<lpage>3193</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.5b00089</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stan</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Fran&#xe7;oso</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>de Camargo</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Febrile temperatures increase <italic>in vitro</italic> antibody affinity for malarial and dengue antigens</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>13</volume> (<issue>4</issue>), <fpage>e0007239</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0007239</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sule</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Western blotting (immunoblotting): history, theory, uses, protocol and problems</article-title>. <source>Biotechniques</source> <volume>75</volume> (<issue>3</issue>), <fpage>99</fpage>&#x2013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.2144/btn-2022-0034</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamil</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>G. S.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Determination of thermodynamic parameters of antigen&#x2013;antibody interaction from real-time kinetic studies</article-title>. <source>Curr. Sci.</source> <volume>82</volume> (<issue>12</issue>), <fpage>1442</fpage>&#x2013;<lpage>1448</lpage>. <pub-id pub-id-type="doi">10.1140/epjb/e2007-00212-6</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Latypov</surname>
<given-names>R. F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lomakin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Vunnum</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Evaluation of effects of pH and ionic strength on colloidal stability of IgG solutions by PEG-induced liquid-liquid phase separation</article-title>. <source>J. Chem. Phys.</source> <volume>145</volume> (<issue>18</issue>), <fpage>185101</fpage>. <pub-id pub-id-type="doi">10.1063/1.4966708</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Towbin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Staehelin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1979</year>). <article-title>Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>76</volume> (<issue>9</issue>), <fpage>4350</fpage>&#x2013;<lpage>4354</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.76.9.4350</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Learning to troubleshoot experiments: flipped classroom activities for PCR &#x26; Western Blot</article-title>. <source>Am. Biol. Teach.</source> <volume>84</volume> (<issue>5</issue>), <fpage>315</fpage>&#x2013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1525/abt.2022.84.5.315</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voets</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>On the antigen-antibody interaction: a thermodynamic consideration</article-title>. <source>Hum. Antibodies</source> <volume>26</volume> (<issue>1</issue>), <fpage>39</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.3233/HAB-170319</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakayama</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Evaluation of temperature effect on the interaction between &#x3b2;-lactoglobulin and anti-&#x3b2;-lactoglobulin antibody by atomic force microscopy</article-title>. <source>Biochemistry</source> <volume>51</volume> (<issue>1</issue>), <fpage>32</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1021/bi201245k</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yukhananov</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chimento</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Marlow</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Western Blot processing optimization: the perfect blot</article-title>. <source>Methods Mol. Biol.</source> <volume>2349</volume>, <fpage>65</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-0716-1585-0_4</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z. B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>An AIE&#x2010;based enzyme&#x2010;activatable fluorescence indicator for Western blot assay: quantitative expression of proteins with reproducible stable signal and wide linear range</article-title>. <source>Aggregate</source> <volume>2</volume> (<issue>2</issue>), <fpage>e22</fpage>. <pub-id pub-id-type="doi">10.1002/agt2.22</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>